Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Deferoxamine Mesylate	145
Overall Study	STARTED	Normal Saline	149
Overall Study	Initiated Study Drug	Deferoxamine Mesylate	144
Overall Study	Initiated Study Drug	Normal Saline	147
Overall Study	90 Day Outcome Obtained	Deferoxamine Mesylate	140
Overall Study	90 Day Outcome Obtained	Normal Saline	143
Overall Study	180 Day Outcome Obtained	Deferoxamine Mesylate	135
Overall Study	180 Day Outcome Obtained	Normal Saline	135
Overall Study	COMPLETED	Deferoxamine Mesylate	137
Overall Study	COMPLETED	Normal Saline	138
Overall Study	NOT COMPLETED	Deferoxamine Mesylate	8
Overall Study	NOT COMPLETED	Normal Saline	11

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02175225/flow